icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
Boston, Massachusetts
March 4-7, 2018
Back grey_arrow_rt.gif
 
 
 
Antiviral Activity of Tenofovir Alafenamide Against HIV-1 with Thymidine Analog Mutation(s) and M184V
 
 
 
 
Reported by Jules Levin
CROI 2018 March 4-7 Boston, MA
 
Na Margot, RR Ram, ME Abram, R Haubrich, C Callebaut
Gilead Sciences, Inc., Foster City, CA
 
HIV Dart/2016: Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog Mutation(s) and M184V - (12/15/16)
 
Antiviral Activity of Tenofovir Alafenamide (TAF) against Major NRTI-Resistant Viruses: Improvement over TDF/TFV is Driven by Higher TFV-DP Loading in Target cells (06/09/13)

AASDL1

AASDL2

AASDL3

AASDL4

AASDL5

AASDL6